Donald R. Nixdorf

Donald R. Nixdorf

Auto-generated profile, based on publicly available information

Donald R. Nixdorf

University of Minnesota

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Oral & Facial Pain and Headache
Verified
Journal Article
Closed access
ESEric Schiffman
Eric Schiffman
RORichard Ohrbach
Richard Ohrbach
ETEdmond Truelove
Edmond Truelove
JLJohn Look
John Look
GAGary Anderson
Gary Anderson
SDSamuel F. Dworkin
Samuel F. Dworkin
Eric Schiffman, DDS, MS/Richard Ohrbach, DDS, PhD/Edmond Truelove, DDS, MSD/John Look, DDS, PhD/Gary Anderson, DDS, MS/Jean-Paul Goulet, DDS, MSD/Thomas List, DDS, Odont Dr/Peter Svensson, DDS, PhD, Dr Odont/Yoly Gonzalez, DDS, MS, MPH/Frank Lobbezoo, DDS, PhD/Ambra Michelotti, DDS/Sharon L. Brooks, DDS, MS/Werner Ceusters, MD/Mark Drangsholt, DDS, PhD/Dominik Ettlin, MD, DDS/Charly Gaul, MD/Louis J. Goldberg, DDS, PhD/Jennifer A. Haythornthwaite, PhD/Lars Hollender, DDS, Odont Dr/Rigmor Jensen, MD, PhD/Mike T. John, DDS, PhD/Antoon De Laat, DDS, PhD/Reny de Leeuw, DDS, PhD/William Maixner, DDS, PhD/Marylee van der Meulen, PhD/Greg M. Murray, MDS, PhD/Donald R. Nixdorf, DDS, MS/Sandro Palla, Dr Med Dent/Arne Petersson, DDS, Odont Dr/Paul Pionchon, DDS, PhD/Barry Smith, PhD/Corine M. Visscher, PT, PhD/Joanna Zakrzewska, MD, FDSRCSI/Samuel F. Dworkin, DDS, PhD: Aims: The original Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I diagnostic algorithms have been demonstrated to be reliable. However, the Validation Project determined that the RDC/TMD Axis I validity was below the target sensitivity of ≥ 0.70 and specificity of ≥ 0.95. Consequently, these empirical results supported the development of revised RDC/TMD Axis I diagnostic algorithms that were subsequently demonstrated to be valid for the most common pain-related TMD and for one temporomandibular joint (TMJ) intra-articular disorder. The original RDC/TMD Axis II instruments were shown to be both reliable and valid. Working from these findings and revisions, two international consensus workshops were convened, from which recommendations were obtained for the finalization of new Axis I diagnostic algorithms and new Axis II instruments. Methods: Through a series of workshops and symposia, a panel of clinical and basic science pain experts modified the revised RDC/TMD Axis I algorithms by using comprehensive searches of published TMD diagnostic literature followed by review and consensus via a formal structured process. The panel?s recommendations for further revision of the Axis I diagnostic algorithms were assessed for validity by using the Validation Project?s data set, and for reliability by using newly collected data from the ongoing TMJ Impact Project?the follow-up study to the Validation Project. New Axis II instruments were identified through a comprehensive search of the literature providing valid instruments that, relative to the RDC/TMD, are shorter in length, are available in the public domain, and currently are being used in medical settings. Results: The newly recommended Diagnostic Criteria for TMD (DC/TMD) Axis I protocol includes both a valid screener for detecting any pain-related TMD as well as valid diagnostic criteria for differentiating the most common pain-related TMD (sensitivity ≥ 0.86, specificity ≥ 0.98) and for one intra-articular disorder (sensitivity of 0.80 and specificity of 0.97). Diagnostic criteria for other common intra-articular disorders lack adequate validity for clinical diagnoses but can be used for screening purposes. Inter-examiner reliability for the clinical assessment associated with the validated DC/TMD criteria for pain-related TMD is excellent (kappa ≥ 0.85). Finally, a comprehensive classification system that includes both the common and less common TMD is also presented. The Axis II protocol retains selected original RDC/TMD screening instruments augmented with new instruments to assess jaw function as well as behavioral and additional psychosocial factors. The Axis II protocol is divided into screening and comprehensive selfreport instrument sets. The screening instruments? 41 questions assess pain intensity, pain-related disability, psychological distress, jaw functional limitations, and parafunctional behaviors, and a pain drawing is used to assess locations of pain. The comprehensive instruments, composed of 81 questions, assess in further detail jaw functional limitations and psychological distress as well as additional constructs of anxiety and presence of comorbid pain conditions. Conclusion: The recommended evidence-based new DC/TMD protocol is appropriate for use in both clinical and research settings. More comprehensive instruments augment short and simple screening instruments for Axis I and Axis II. These validated instruments allow for identification of patients with a range of simple to complex TMD presentations. J Oral Facial Pain Headache 2014;28:6?27. doi: 10.11607/jop.1151

3 October 2024 in Cranio®
Verified
Journal Article
Open access
DMDaniele Manfredini
Daniele Manfredini
BHBirgitta Haggman-Henrikson
Birgitta Haggman-Henrikson
AJAhmad Al Jagshi
Ahmad Al Jagshi
LBLene Baad-Hansen
Lene Baad-Hansen
EBEmma Beecroft
Emma Beecroft
IMInternational Network for Orofacial Pain and Related Disorders Methodology
International Network for Orofacial Pain and Related Disorders Methodology
To present a list of key points for good Temporomandibular Disorders (TMDs) clinical practice on behalf of the International Network for Orofacial Pain and Related Disorders Methodology (INfORM) group of the International Association for Dental, Oral and Craniofacial Research (IADR). An open working group discussion was held at the IADR General Session in New Orleans (March 2024), where members of the INfORM group finalized the proposal of a list of 10 key points. The key points covered knowledge on the etiology, diagnosis, and treatment. They represent a summary of the current standard of care for management of TMD patients. They are in line with the current need to assist general dental practitioners advance their understanding and prevent inappropriate treatment. The key points can be viewed as a guiding template for other national and international associations to prepare guidelines and recommendations on management of TMDs adapted to the different cultural, social, educational, and healthcare requirements.

1 June 2011 in Journal of Endodontics
Verified
Journal Article
Closed access
DIDjaudat Sh Idiyatullin
Djaudat Sh Idiyatullin
CCCurt Corum
Curt Corum
SMSteen Moeller
Steen Moeller
HPHari S. Prasad
Hari S. Prasad
MGMichael Garwood
Michael Garwood
DNDonald R. Nixdorf
Donald R. Nixdorf

1 February 2010 in Journal of Endodontics
Verified
Journal Article
Closed access
DNDonald R. Nixdorf
Donald R. Nixdorf
EMEstephan J. Moana-Filho
Estephan J. Moana-Filho
ALAlan S. Law
Alan S. Law
LMLisa A. McGuire
Lisa A. McGuire
JHJames S. Hodges
James S. Hodges
MJMike T. John
Mike T. John

1 October 2015 in Journal of Dentistry
Verified
Journal Article
Closed access
SSS.S. Shueb
S.S. Shueb
DND.R. Nixdorf
D.R. Nixdorf
MJM.T. John
M.T. John
BAB. Fonseca Alonso
B. Fonseca Alonso
JDJ. Durham
J. Durham

1 October 2002 in Pain
Verified
Journal Article
Closed access
DNDonald R. Nixdorf
Donald R. Nixdorf
GHGiseon Heo
Giseon Heo
PMPaul W. Major
Paul W. Major
The purpose of this study was to determine whether botulinum toxin A (BTX-A) was efficacious for the treatment of chronic moderate to severe jaw muscle pain in females. This was a randomized double-blind, placebo-controlled crossover trial of BTX-A. Twenty five units injected into each temporalis muscle and 50 U injected into each masseter muscle using three sites per muscle with 0.2 cm(3) per site. Data were collected at baseline, 8, 16, 24 weeks, with crossover occurring at 16 weeks. Primary outcome variables were pain intensity and unpleasantness, measured by horizontal visual analog scale (VAS). Secondary outcome variables were maximum interincisal opening without and irrespective of pain, muscle palpation tenderness (12 points), and four general questions. Fifteen female patients were enrolled (18-45 years), but only ten completed the trial. Of those who finished, no statistically significant difference was found in pain intensity (P=0.10), unpleasantness (P=0.40), palpation muscle tenderness (P=0.91), or the three general questions (P=0.64, P=0.66, P=0.67). Statistical significance was achieved for maximum opening without pain (P=0.02) and irrespective of pain (P=0.005) with the BTX-A arm having a relative decreased opening. No statistically significant difference was observed in any outcome measures except maximum opening, which showed BTX-A patient opening less wide than placebo. The results do not support the use of BTX-A in the treatment of moderate to severe jaw muscle pain in this patient population.